+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Opioid Narcotics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6142780
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The opioid narcotics market is undergoing significant transformation, shaped by regulation, innovation, and shifting clinical priorities. Senior leaders navigating this landscape must address the balance of therapeutic necessity and oversight amid evolving industry dynamics.

Market Snapshot: Opioid Narcotics Market Dynamics

The opioid narcotics market presents a complex outlook driven by continuous advances in pain management, regulatory recalibration, and stakeholder collaboration. Manufacturers, healthcare providers, and policy makers operate within a landscape that demands robust compliance, adaptive innovation, and optimized access strategies, especially as chronic and acute pain prevalence necessitates continued reliance on opioid-based analgesics. Heightened public health concerns have sharpened regulatory oversight, requiring harmonization of commercial goals with safety imperatives. Cross-sector partnerships, digital health integrations, and scientific development are enabling the industry to evolve toward more patient-centric and controlled therapeutic approaches.

Scope & Segmentation

  • Route of Administration: Injectable, nasal, oral, rectal, and transdermal delivery mechanisms, each influencing onset time, compliance, and appropriate clinical context.
  • Product Type: Branded drugs that integrate abuse-deterrent technologies and proprietary delivery systems, alongside generic formulations designed to extend access and cost efficiency.
  • Molecule Type: Analysis includes fentanyl, hydrocodone, morphine, and oxycodone, covering diverse risk profiles and use cases.
  • Formulation Type: Extended release and immediate release modalities tailored to chronic versus acute pain scenarios.
  • Distribution Channel: Hospital pharmacies, online pharmacies, and retail channels, all shaping availability and monitoring capabilities.
  • End User: Distinct demand from ambulatory care, home healthcare, and hospital settings, reflecting varied pain management protocols.
  • Regions Covered: Americas (including key U.S. states such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa (notable countries: United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies Profiled: Johnson & Johnson, Purdue Pharma L.P., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Viatris Inc., Endo International plc, AbbVie Inc., Hikma Pharmaceuticals PLC, Pfizer Inc., and Sandoz International GmbH.

Key Takeaways for Senior Decision-Makers

  • Regulatory landscape shifts continue to drive the adoption of advanced abuse-deterrent technologies and digital monitoring platforms, compelling companies to innovate without compromising compliance.
  • Collaboration across pharmaceutical, technology, and healthcare sectors accelerates integration of smart delivery systems that enhance patient safety and enable real-time usage insights.
  • Patient-centric care models are transforming clinical trial designs and post-market surveillance, relying increasingly on real-world evidence and adaptive methodologies.
  • Market access and operational planning are influenced by fluctuating cost structures, with supply chain resilience gaining importance as manufacturers adapt sourcing and production strategies.
  • Regional differences require precise market entry tactics, with mature healthcare systems, expanding infrastructure, and varied regulatory regimes presenting unique opportunities and challenges.
  • Strategic portfolio management, including targeted partnerships, value-driven educational programs, and payer engagement, supports competitive positioning and sustainable growth.

Tariff Impact on Opioid Narcotics Supply Chains

Recent United States tariffs on imported opioid precursors and API components have disrupted procurement strategies and raised input costs for manufacturers. Resulting adjustments span production planning, supply chain restructuring, and logistics negotiations, as companies seek to mitigate pricing pressures and ensure compliance. Tariffs also impact cross-border collaborations and global clinical trial budgets, intensifying the need for resilient domestic supply strategies and collaborative platforms to harmonize responses.

Methodology & Data Sources

The analysis utilizes a hybrid methodology, combining primary insights from interviews with regulatory officials, clinicians, and key opinion leaders, as well as secondary sources such as peer-reviewed journals, patent filings, and public health databases. Comprehensive data triangulation ensures accuracy, and findings are validated through expert panels and multi-tier review processes.

Why This Report Matters

  • Enables leaders to make data-driven decisions on market entry, investment, and advocacy by mapping evolving regulatory, technological, and supply chain dynamics.
  • Supports optimization of product portfolio, risk mitigation, and access strategies aligned with clinical, commercial, and public health priorities.
  • Offers actionable recommendations designed to enhance operational continuity and competitive differentiation in a complex therapeutic area.

Conclusion

The opioid narcotics sector is characterized by fast-paced regulatory developments, technological innovation, and regional variation. Leaders who integrate cross-disciplinary insight and maintain operational agility will navigate evolving challenges while supporting sustainable, patient-focused growth.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of abuse-deterrent formulations to curb opioid misuse while maintaining analgesic efficacy
5.2. Impact of increasing regulatory scrutiny on prescription opioid supply chain compliance costs
5.3. Growth of telemedicine prescriptions for chronic pain management and associated opioid consumption trends
5.4. Rising adoption of non-opioid pain management guidelines driving demand for alternative therapeutics
5.5. Effect of evolving Medicaid and Medicare reimbursement policies on high-dose opioid prescribing patterns
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Opioid Narcotics Market, by Route Of Administration
8.1. Introduction
8.2. Injectable
8.3. Nasal
8.4. Oral
8.5. Rectal
8.6. Transdermal
9. Opioid Narcotics Market, by Product Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Opioid Narcotics Market, by Molecule Type
10.1. Introduction
10.2. Fentanyl
10.3. Hydrocodone
10.4. Morphine
10.5. Oxycodone
11. Opioid Narcotics Market, by Formulation Type
11.1. Introduction
11.2. Extended Release
11.3. Immediate Release
12. Opioid Narcotics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Opioid Narcotics Market, by End User
13.1. Introduction
13.2. Ambulatory Care
13.3. Home Healthcare
13.4. Hospitals
14. Americas Opioid Narcotics Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Opioid Narcotics Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Opioid Narcotics Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Purdue Pharma L.P.
17.3.3. Mallinckrodt plc
17.3.4. Teva Pharmaceutical Industries Ltd.
17.3.5. Viatris Inc.
17.3.6. Endo International plc
17.3.7. AbbVie Inc.
17.3.8. Hikma Pharmaceuticals PLC
17.3.9. Pfizer Inc.
17.3.10. Sandoz International GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. OPIOID NARCOTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OPIOID NARCOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. OPIOID NARCOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. OPIOID NARCOTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. OPIOID NARCOTICS MARKET: RESEARCHAI
FIGURE 28. OPIOID NARCOTICS MARKET: RESEARCHSTATISTICS
FIGURE 29. OPIOID NARCOTICS MARKET: RESEARCHCONTACTS
FIGURE 30. OPIOID NARCOTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OPIOID NARCOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OPIOID NARCOTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OPIOID NARCOTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FENTANYL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HYDROCODONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY MORPHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY OXYCODONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OPIOID NARCOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES OPIOID NARCOTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. CANADA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. CANADA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 94. CANADA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 95. CANADA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. CANADA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. CANADA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. MEXICO OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA OPIOID NARCOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. GERMANY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 168. GERMANY OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 169. GERMANY OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. GERMANY OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. GERMANY OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. FRANCE OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 180. FRANCE OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 181. FRANCE OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. FRANCE OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. FRANCE OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ITALY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. ITALY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ITALY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ITALY OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 203. ITALY OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 204. ITALY OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 205. ITALY OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. ITALY OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. ITALY OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SPAIN OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 216. SPAIN OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 217. SPAIN OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. SPAIN OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. SPAIN OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. DENMARK OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 264. DENMARK OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 265. DENMARK OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. DENMARK OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. DENMARK OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. QATAR OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. QATAR OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. QATAR OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. QATAR OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. QATAR OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 287. QATAR OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 288. QATAR OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 289. QATAR OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. QATAR OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. QATAR OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. QATAR OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FINLAND OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. FINLAND OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. FINLAND OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 300. FINLAND OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 301. FINLAND OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FINLAND OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FINLAND OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FINLAND OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. EGYPT OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. EGYPT OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. EGYPT OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. EGYPT OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 334. EGYPT OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 335. EGYPT OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 336. EGYPT OPIOID NARCOTICS MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 337. EGYPT OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. EGYPT OPIOID NARCOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. EGYPT OPIOID NARCOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. EGYPT OPIOID NARCOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. TURKEY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. TURKEY OPIOID NARCOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. TURKEY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 344. TURKEY OPIOID NARCOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 345. TURKEY OPIOID NARCOTICS MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 346. TURKEY OPIOID NA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Opioid Narcotics market report include:
  • Johnson & Johnson
  • Purdue Pharma L.P.
  • Mallinckrodt plc
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Endo International plc
  • AbbVie Inc.
  • Hikma Pharmaceuticals PLC
  • Pfizer Inc.
  • Sandoz International GmbH